Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Hebert

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|April 1, 1996
Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trialsM Moser, P R Hebert
Archives of Internal Medicine|November 14, 2000
An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular diseaseP R Hebert, C H Hennekens
Journal of the American Society of Nephrology : JASN|October 1, 1992
Pharmacologic therapy of mild to moderate hypertension: possible generalizability to diabeticsP R Hebert, J E Manson, C H Hennekens
Annals of Internal Medicine|May 15, 1996
Cholesterol reduction: weighing the benefits and risksJ M Gaziano, P R Hebert, C H Hennekens
Statistics in Medicine|April 1, 1987
Implications of overviews of randomized trialsC H Hennekens, J E Buring, P R Hebert
Archives of Internal Medicine|January 9, 1995
An overview of trials of cholesterol lowering and risk of strokeP R Hebert, J M Gaziano, C H Hennekens
Lancet (London, England)|June 19, 1993
Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?P M Ridker, P R Hebert, V Fuster, et al.
Journal of the American College of Cardiology|June 1, 1995
Antithrombotic therapy for acute myocardial infarctionC J O'Donnell, P M Ridker, P R Hebert, et al.
JAMA|July 23, 1997
Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trialsP R Hebert, J M Gaziano, K S Chan, et al.
Archives of Internal Medicine|March 8, 1993
Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart diseaseP R Hebert, M Moser, J Mayer, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|April 1, 1996
Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trialsM Moser, P R Hebert
Archives of Internal Medicine|November 14, 2000
An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular diseaseP R Hebert, C H Hennekens
Journal of the American Society of Nephrology : JASN|October 1, 1992
Pharmacologic therapy of mild to moderate hypertension: possible generalizability to diabeticsP R Hebert, J E Manson, C H Hennekens
Annals of Internal Medicine|May 15, 1996
Cholesterol reduction: weighing the benefits and risksJ M Gaziano, P R Hebert, C H Hennekens
Statistics in Medicine|April 1, 1987
Implications of overviews of randomized trialsC H Hennekens, J E Buring, P R Hebert
Archives of Internal Medicine|January 9, 1995
An overview of trials of cholesterol lowering and risk of strokeP R Hebert, J M Gaziano, C H Hennekens
Lancet (London, England)|June 19, 1993
Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?P M Ridker, P R Hebert, V Fuster, et al.
Journal of the American College of Cardiology|June 1, 1995
Antithrombotic therapy for acute myocardial infarctionC J O'Donnell, P M Ridker, P R Hebert, et al.
JAMA|July 23, 1997
Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trialsP R Hebert, J M Gaziano, K S Chan, et al.
Archives of Internal Medicine|March 8, 1993
Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart diseaseP R Hebert, M Moser, J Mayer, et al.
Pageof 4